Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 68

1 of 24 © Boardworks Ltd 2008

Task:
1) Draw and label a diagram of the heart – no
help.
2) Compare the diagram with the one you have
drawn. Compare labels. Draw the correct
structure.
3) Cover this up. Re-draw and label the heart.

2 of 24 © Boardworks Ltd 2008


3 of 24 © Boardworks Ltd 2008
4 of 24 © Boardworks Ltd 2008
5 of 24 © Boardworks Ltd 2008
The human heart
The heart is a muscular
organ located between the
lungs in the centre of the
chest (thorax), and is about
the size of a fist.
It pumps blood continuously
around the body. An organism
can lose conscious within just
a few seconds if the brain is
deprived of blood.

In foetuses, the heart begins


beating about 5–6 weeks after
conception.

6 of 24 © Boardworks Ltd 2008


Cardiac muscle
The heart mainly consists of cardiac muscle tissue, which
like smooth muscle (but not skeletal muscle), contracts
involuntarily.

Cardiac muscle is
made up of cells that
are connected by
cytoplasmic bridges.
This enables electrical
impulses to pass
through the tissue.

It contains large numbers of mitochondria and myoglobin


molecules.

7 of 24 © Boardworks Ltd 2008


Structure of the heart

8 of 24 © Boardworks Ltd 2008


What structure?

9 of 24 © Boardworks Ltd 2008


Blood flow through the heart

10 of 24 © Boardworks Ltd 2008


11 of 24 © Boardworks Ltd 2008
The cardiac cycle

12 of 24 © Boardworks Ltd 2008


Interactive heart

13 of 24 © Boardworks Ltd 2008


Cardiac output
The amount of blood pumped around the body is called the
cardiac output, and depends on two factors:

 the stroke volume – the volume of blood pumped by the


left ventricle in each heart beat. A typical value for an
adult at rest is 75 ml.
 the heart rate – the number of times the heart beats per
minute. A typical value for an adult at rest is 70 bpm.

cardiac output = stroke volume × heart rate

A typical resting cardiac output is 4–6 litres per minute.


This can rise to as much as 40 litres per minute in highly
trained endurance athletes.

14 of 24 © Boardworks Ltd 2008


Pacemaker cells of the heart
The heart can beat without any input from the nervous
system as longs as its cells stay alive. This is due to
myogenic contraction.

Muscle cells (myocytes) in the heart have a slight


electrical charge across their membrane. They are
polarized. When the charge is reversed, they are said to
be depolarized and this causes them to contract.

Depolarization is initiated in a region of the heart called the


sinoatrial node (SAN) – also known as the pacemaker –
which is in the wall of the right atrium.

15 of 24 © Boardworks Ltd 2008


Myogenic stimulation of the heart

16 of 24 © Boardworks Ltd 2008


Interactive heart

17 of 24 © Boardworks Ltd 2008


Artificial pacemakers
Artificial pacemakers are devices implanted in people whose
heart’s electrical conduction system is not working properly.

Problems include the SAN not firing, and the blockage or


disruption of impulses between the SAN and AVN, or in the
bundle of His.

Pacemakers monitor the


heart’s electrical activity and
stimulate the ventricles or atria
to contract when necessary.
Impulses are transmitted
down electrodes implanted in
the muscular walls.

18 of 24 © Boardworks Ltd 2008


The cardiac cycle

19 of 24 © Boardworks Ltd 2008


What are electrocardiograms?
The electrical activity of the heart can be monitored by
an electrocardiograph.

Several electrodes are


attached to specific places
on a person’s chest and
limbs. These detect
changes in polarization in
the heart by measuring
current at the skin surface.

The leads are connected to


a machine that draws an
electrocardiogram (ECG).

20 of 24 © Boardworks Ltd 2008


Components of an ECG trace

21 of 24 © Boardworks Ltd 2008


ECG in diagnosis
ECGs are used to diagnose problems with the heart, as
variations in different components of the trace can
indicate a disease or other abnormality.

An ECG may be taken


while the patient is relaxed
or it may be taken before,
during and after exercise.

This is called a ‘stress test’


and usually involves the
patient exercising on a
treadmill while attached to
an ECG machine.

22 of 24 © Boardworks Ltd 2008


Abnormal ECGs

23 of 24 © Boardworks Ltd 2008


24 of 24 © Boardworks Ltd 2008
Glossary

25 of 24 © Boardworks Ltd 2008


What’s the keyword?

26 of 24 © Boardworks Ltd 2008


Multiple-choice quiz

27 of 24 © Boardworks Ltd 2008


28 of 52 © Boardworks Ltd 2008
Worldwide deaths due to CVD, 2002

29 of 52 © Boardworks Ltd 2008


What is coronary heart disease?
Coronary heart disease (CHD) is a disease of the arteries
supplying the heart (coronary arteries). Almost one-fifth of
all deaths in the UK in 2005 were due to CHD.

The major cause of CHD is


atherosclerosis: a thickening of
arteries caused by a build-up of
fatty plaques (atheromas) on the
inside walls.

Atherosclerosis can eventually


lead to a reduced blood supply
(ischaemia) to tissues, with
potentially fatal consequences.

30 of 52 © Boardworks Ltd 2008


Trends in CVD death rates

31 of 52 © Boardworks Ltd 2008


Gender, age, CHD and stroke

32 of 52 © Boardworks Ltd 2008


Scientist case study

33 of 52 © Boardworks Ltd 2008


Development of atherosclerosis

34 of 52 © Boardworks Ltd 2008


CHD risk factors
Hundreds of risk factors for CHD and stroke have been
identified. The major ones are:

Modifiable Non-modifiable
high blood pressure advancing age
high blood cholesterol male gender
tobacco smoking family history of the disease
physical inactivity ethnicity/race
obesity
diabetes mellitus
others: stress, alcohol

35 of 52 © Boardworks Ltd 2008


Hypertension and CHD
High blood pressure (hypertension) is a major risk factor for
CHD and other cardiovascular diseases.

Hypertension is defined as
systolic blood pressure above
140 mmHg and/or diastolic
blood pressure above 90 mmHg.

Hypertension puts strain on the


heart and blood vessels,
increasing the risk of
aneurysm or thrombosis. It is
sometimes called the ‘silent
killer’ because it can develop
without symptoms.

36 of 52 © Boardworks Ltd 2008


Hypertension and CHD

37 of 52 © Boardworks Ltd 2008


Cholesterol and lipoproteins
Cholesterol is a soft waxy lipid that has a vital role as a
component of cell membranes, where it regulates fluidity.
Cholesterol is insoluble in blood, so
it is transported by lipoproteins.
These are spherical complexes
consisting of:

 an outer layer of phospholipids,


studded with proteins
 an inner core of trigylcerides
and cholesterol.

Two major types of lipoprotein are low-density lipoprotein


(LDL) and high-density lipoprotein (HDL).

38 of 52 © Boardworks Ltd 2008


High blood cholesterol levels and CHD
LDLs generally transport cholesterol from the
liver to body tissues, depositing it on the
walls of blood vessels. In high levels,
it contributes to atherosclerosis.

Eating a diet high in saturated fat


is the biggest cause of elevated LDL cholesterol levels.

LDL cholesterol levels can be reduced by regular exercise,


eating plenty of fibre and a diet rich in polyunsatured fats.

HDLs generally transport cholesterol away from the tissues


to the liver, where the cholesterol is metabolized. High levels
of HDL cholesterol are linked to a reduced risk of CHD.

39 of 52 © Boardworks Ltd 2008


Smoking and CHD
Smoking tobacco is a major cause of CHD, and smokers are
at a higher risk of developing CVD than lung cancer.

Smoking increases the risk of CHD in several ways:


 it damages and weakens the endothelial lining of blood
vessels
 it increases clotting and the development of atheromas
 it lowers HDL cholesterol and raises LDL cholesterol levels
 nicotine increases blood pressure and heart rate, and
constricts blood vessels
 carbon monoxide reduces the amount of oxygen that
blood can carry.

40 of 52 © Boardworks Ltd 2008


Effects of CHD: heart attack
The most dangerous symptom/result of CHD is a heart attack,
known as a myocardial infarction (MI).

An MI occurs when the blood


supply to part of the heart muscle
(myocardium) is interrupted.
This causes oxygen deprivation
and subsequent tissue damage.

The most common symptom is


chest pain, but shortness of breath,
excessive sweating, nausea and
weakness may also be present. Loss
of consciousness and death can occur.

41 of 52 © Boardworks Ltd 2008


Effects of CHD: angina
A less severe symptom of
CHD is angina pectoris.
This is a tight, gripping
chest pain or ache, similar
to indigestion, which
commonly occurs during
physical activity.

The narrowing of the coronary arteries results in inadequate


blood and oxygen supply, forcing the heart to respire
anaerobically, and causing a build-up of lactic acid.

The pain normally subsides with rest, once the demand on


the heart has dropped and it can respire aerobically.

42 of 52 © Boardworks Ltd 2008


Diagnosing heart disease

43 of 52 © Boardworks Ltd 2008


How does CHD develop?

44 of 52 © Boardworks Ltd 2008


Identifying CHD risk factors

45 of 52 © Boardworks Ltd 2008


Reducing the risk of CHD
Ensuring a healthy lifestyle can make a significant difference
to a person’s risk of developing CHD.
These changes aim to reduce blood pressure and blood
cholesterol, and reduce weight if overweight or obese. Key
steps include:
 stopping smoking
 regular cardiovascular exercise – about 30 mins of
moderate exercise several times a week
 a healthy diet – low in saturated fats (including trans fats)
and salt, high in fibre, fresh fruit/vegetables, and
moderate mono/polunsaturated fats
 reducing alcohol intake.

46 of 52 © Boardworks Ltd 2008


Treating CHD: medication

47 of 52 © Boardworks Ltd 2008


Treating CHD: surgery
Surgery is used in the treatment or prevention of CHD, stroke
or MI. The type of operation depends on the severity and
location of atherosclerosis, and factors such as whether the
patient has diabetes.

A coronary artery bypass


graft (CABG) is an operation
in which arteries from
elsewhere in the body (e.g.
legs or chest) are grafted on
to coronary arteries to
bypass blocked regions.

Single, double, triple bypass refers to the number of coronary


arteries that are bypassed.

48 of 52 © Boardworks Ltd 2008


Treating CHD: coronary angioplasty

49 of 52 © Boardworks Ltd 2008


50 of 52 © Boardworks Ltd 2008
Respiratory diseases
Respiratory diseases are one of the biggest causes of death
worldwide.

Respiratory diseases affect the lungs, bronchi, trachea and


throat. They can be mild (e.g. cold) or life-threatening (e.g.
pneumonia, lung cancer).
Chronic obstructive pulmonary disorder (COPD) is a
term for a group of diseases that cause a reduction in the
airflow in the lungs and which are not fully reversible.

Two of the more serious types of COPD are chronic


bronchitis and emphysema, and are both usually caused
by smoking.

51 of 52 © Boardworks Ltd 2008


COPD: chronic bronchitis
Chronic bronchitis is a bronchi
narrowing of the bronchi. It
is characterized by: normal
airway
 a persistent cough that
produces phlegm - due
to an increased number mucus
and size of goblet cells inflammed
airway
 shortness of breath and wheezing - irritants in cigarette
smoke cause inflammation in the lining of the bronchioles.
Over time this leads to scarring and narrowing of the
bronchioles, reducing airflow.

52 of 52 © Boardworks Ltd 2008


COPD: emphysema
Emphysema is a gradual breakdown of alveolar walls and
damage to terminal bronchioles and alveolar capillaries.

This reduces the efficiency of gas exchange, causing


chronic breathlessness and hyperventilation.

Using this photo of


healthy lung tissue
(left) and emphysema
lung tissue (right), can
you explain why gas
exchange is less
efficient in
emphysema?

53 of 52 © Boardworks Ltd 2008


Diagnosing COPD
There is no one single test for COPD. Diagnosis depends
on taking into account a patient’s risk factors (e.g. whether
they smoke, their age), their symptoms and clinical tests.

Testing the patient’s lung


function using spirometry
is essential. It can
determine whether there is
airway obstruction and can
help exclude the possibility
of other respiratory
diseases, such as asthma
or lung cancer.

54 of 52 © Boardworks Ltd 2008


Determining lung function

55 of 52 © Boardworks Ltd 2008


Treating COPD
Stopping smoking is the single most important step in
slowing the decline in lung function in people with COPD.

Medicines commonly prescribed to treat COPD include


bronchodilators, which widen the airways by relaxing
smooth muscles, and corticosteroids, which act as anti-
inflammatories.
Oxygen therapy,
especially for people
with emphysema, may
be required for most of
each day.

56 of 52 © Boardworks Ltd 2008


What is asthma?
Asthma is a chronic condition in which the airways
occasionally narrow and become inflamed, limiting airflow.

Asthma causes difficulty


breathing, wheezing and
chest tightness, and can
be mild or life-threatening.

Asthma is triggered by a
range of stimuli, such as
allergens, dust, exercise,
stress and infections.

Treatment is with bronchodilators, corticosteroids, or a


combination of the two.

57 of 52 © Boardworks Ltd 2008


Lung cancer
Lung cancer is the biggest cause of cancer-related deaths in
men and second-biggest cause in women. About 90% of
cases are caused by smoking.

Most incidences of lung


cancer are due to
uncontrolled growth of
epithelial cells lining the
airways. Cancers arising
from these cells are
called carcinomas.

Symptoms include shortness of breath, coughing (including


coughing up blood) and loss of weight.

58 of 52 © Boardworks Ltd 2008


Lung cancer
Lung cancer generally develops quite slowly. By the time it
has been diagnosed, the cancer may have spread to other
areas of the body. This is called metastasis, and makes it
difficult to treat successfully.

Lung cancer can be seen


on an X-ray or a CT scan,
and diagnosis is usually
confirmed after a small
sample of tissue is taken
(a biopsy) and analysed.

Like many other cancers, lung cancer is treated by surgery,


chemotherapy and/or radiotherapy.

59 of 52 © Boardworks Ltd 2008


Cancer statistics

60 of 52 © Boardworks Ltd 2008


Smoking and lung cancer

61 of 52 © Boardworks Ltd 2008


Smoking and lung cancer: epidemiology
The first solid epidemiological evidence that smoking
increased the risk of lung cancer came from a 1950 study by
Richard Doll, a British doctor and epidemiologist, and Austin
Bradford Hill, a British epidemiologist and statistician.

Before their study, it was unclear whether the rapid rise in


lung cancer was due to smoking or other atmospheric
pollution, such as exhaust fumes, industrial plants or tarmac.

Their study of over 1,700 men and women in London


concluded that: “The risk of developing the disease
increases in proportion to the amount smoked. It may be
50 times as great among those who smoke 25 or more
cigarettes a day as among non-smokers.”

62 of 52 © Boardworks Ltd 2008


Smoking and health: epidemiology
Following Doll and Hill’s research, a large-scale study into the
health and smoking habits of British male doctors began in
1950, continuing with periodic updates until 2001.

Two of the main findings of this British Doctors Study were:

 life-long smokers died, on average, 10 years earlier than


non-smokers

 the earlier smokers stop smoking, the more chance they


have of avoiding reduced life expectancy.

63 of 52 © Boardworks Ltd 2008


Which respiratory disease?

64 of 52 © Boardworks Ltd 2008


65 of 52 © Boardworks Ltd 2008
Glossary

66 of 52 © Boardworks Ltd 2008


What’s the keyword?

67 of 52 © Boardworks Ltd 2008


Multiple-choice quiz

68 of 52 © Boardworks Ltd 2008

You might also like